Novonix Ltd. buy krebskrebs
Start price
22.02.21
/
50%
€2.42
Target price
22.02.22
€3.00
Performance (%)
39.59%
End price
23.02.22
€3.38
Summary
This prediction ended on 23.02.22 with a price of €3.38. With a performance of 39.59% the BUY prediction by krebskrebs was a big success. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novonix Ltd. | - | - | - | - |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % | 60,42 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % | 87,82 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % | 66,93 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % | 60,46 % |
Comments by krebskrebs for this prediction
In the thread Novonix Ltd. diskutieren
In the thread Trading Novonix Ltd.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten